ES5565H1 - PHARMACEUTICAL COMPOSITION FOR THE HEALING OF WOUNDS AND ULCERS OF ANY GENDER. - Google Patents

PHARMACEUTICAL COMPOSITION FOR THE HEALING OF WOUNDS AND ULCERS OF ANY GENDER.

Info

Publication number
ES5565H1
ES5565H1 ES1876005565A ES1876005565A ES5565H1 ES 5565 H1 ES5565 H1 ES 5565H1 ES 1876005565 A ES1876005565 A ES 1876005565A ES 1876005565 A ES1876005565 A ES 1876005565A ES 5565 H1 ES5565 H1 ES 5565H1
Authority
ES
Spain
Prior art keywords
ulcers
wounds
gender
healing
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES1876005565A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES1876005565A priority Critical patent/ES5565H1/en
Publication of ES5565H1 publication Critical patent/ES5565H1/en
Expired legal-status Critical Current

Links

ES1876005565A 1876-11-21 1876-11-21 PHARMACEUTICAL COMPOSITION FOR THE HEALING OF WOUNDS AND ULCERS OF ANY GENDER. Expired ES5565H1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES1876005565A ES5565H1 (en) 1876-11-21 1876-11-21 PHARMACEUTICAL COMPOSITION FOR THE HEALING OF WOUNDS AND ULCERS OF ANY GENDER.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES1876005565A ES5565H1 (en) 1876-11-21 1876-11-21 PHARMACEUTICAL COMPOSITION FOR THE HEALING OF WOUNDS AND ULCERS OF ANY GENDER.

Publications (1)

Publication Number Publication Date
ES5565H1 true ES5565H1 (en) 1877-02-21

Family

ID=39850697

Family Applications (1)

Application Number Title Priority Date Filing Date
ES1876005565A Expired ES5565H1 (en) 1876-11-21 1876-11-21 PHARMACEUTICAL COMPOSITION FOR THE HEALING OF WOUNDS AND ULCERS OF ANY GENDER.

Country Status (1)

Country Link
ES (1) ES5565H1 (en)

Similar Documents

Publication Publication Date Title
Abazari et al. A systematic review on classification, identification, and healing process of burn wound healing
Costa et al. Effects of Carvacrol, Thymol and essential oils containing such monoterpenes on wound healing: A systematic review
Ramos-Torrecillas et al. Effectiveness of platelet-rich plasma and hyaluronic acid for the treatment and care of pressure ulcers
Hashemi et al. The review on properties of Aloe vera in healing of cutaneous wounds
Mokos et al. Current therapeutic approach to hypertrophic scars
Dealey The care of wounds: a guide for nurses
Essa et al. Comparative study between silver nanoparticles dressing (SilvrSTAT Gel) and conventional dressing in diabetic foot ulcer healing: a prospective randomized study
Cancio et al. Guidelines for burn care under austere conditions: surgical and nonsurgical wound management
Buzzi et al. Therapeutic effectiveness of a Calendula officinalis extract in venous leg ulcer healing
Mabrouk et al. Moist occlusive dressing (Aquacel® Ag) versus moist open dressing (MEBO®) in the management of partial-thickness facial burns: a comparative study in Ain Shams University
Saba et al. Clinical evaluation comparing the efficacy of Aquacel® Ag Hydrofiber® dressing versus petrolatum gauze with antibiotic ointment in partial-thickness burns in a pediatric burn center
Rezai et al. Effect of oral Calendula officinalis on second-degree burn wound healing
Gwarzo et al. Recent advances and future prospects in topical creams from medicinal plants to expedite wound healing: a review
Campanati et al. Effect of allium cepa‐allantoin‐pentaglycan gel on skin hypertrophic scars: clinical and video‐capillaroscopic results of an open‐label, controlled, nonrandomized clinical trial
Russo et al. Clinical Evaluation of the Efficacy and Tolerability of Rigenase® and Polyhexanide (Fitostimoline® Plus) vs. Hyaluronic Acid and Silver Sulfadiazine (Connettivina® Bio Plus) for the Treatment of Acute Skin Wounds: A Randomized Trial
Suzuki-Banhesse et al. Effect of atorvastatin on wound healing in rats
Toledo et al. Effect of pycnogenol on the healing of venous ulcers
Meekul et al. A randomized controlled trial on the outcome in comparing an alginate silver dressing with a conventional treatment of a necrotizing fasciitis wound
Kheiri et al. The effects of Alkanna tinctoria Tausch on split-thickness skin graft donor site management: a randomized, blinded placebo-controlled trial
Valentine et al. The efficacy of a novel chitosan gel on hemostasis after endoscopic sinus surgery in a sheep model of chronic rhinosinusitis
Ciftciler et al. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)
Avijgan Phytotherapy: an alternative treatment for non-healing ulcers
ES5565H1 (en) PHARMACEUTICAL COMPOSITION FOR THE HEALING OF WOUNDS AND ULCERS OF ANY GENDER.
Simsek et al. Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper
Enoch et al. Dystrophic calcification as a cause for non healing leg ulcers